NIAID Strategic Plan for COVID-19 Research to Focus on Four Key Priorities
The National Institute of Allergy and Infectious Diseases {(NIAID) Bethesda, MD, USA}, part of the National Institutes of Health, has provided details of its plan for accelerating research to diagnose, prevent and treat COVID-19. More...27 Apr 2020
Artificial Intelligence Enables Rapid COVID-19 Lung Imaging Analysis
Radiologists and physicians at UC San Diego Health (San Diego, CA, USA) are now using artificial intelligence (AI) to augment lung imaging analysis in a clinical research study enabled by Amazon Web Services (AWS). More...25 Apr 2020
New Biosensor Detects COVID-19 Virus in Air
A team of researchers from Switzerland has succeeded in developing a novel sensor for detecting the new coronavirus that could be used to measure the concentration of the virus in the environment, such as in places where there are many people or in hospital ventilation systems. More...25 Apr 2020
Baxter Blood Purification Filter Secures US FDA Emergency Use Authorization for COVID-19 Treatment
Baxter International Inc. (Deerfield, IL, USA) has received emergency use authorization (EUA) from the US FDA for the company’s Oxiris filter set to treat patients who have confirmed COVID-19 and have been admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure in need of blood purification therapy to reduce pro-inflammatory cytokine levels, including use in continuous renal replacement therapy (CRRT). More...25 Apr 2020
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Documentation System For Blood Banks
HettInfo II
New
Mattress Replacement System
Carilex DualPlus
In Other News
MIT’s COVID-19 Vaccine Could Potentially Reach Billions
Gilead’s Remdesivir Trial Fails to Show Improvement in Patients with Severe COVID-19
Dogs Could Assist in Mass COVID-19 Infection Screening by Sniffing Out Coronavirus
International Hospital Federation (IHF) Rolls Out Response Efforts to COVID-19
AstraZeneca Initiates Phase III Trial of Diabetes Drug Farxiga (Dapagliflozin) for COVID-19 Treatment
Dynavax and Valneva to Jointly Advance Development of COVID-19 Vaccine
AI-Based Triage and Monitoring System Predicts Spread of Coronavirus
MigVax Raises USD 12 Million for Development of Oral COVID-19 Sub-Unit Vaccine
SD Biosensor Coronavirus PCR Test Receives FDA Emergency Use Authorization
J&J Makes Emergent BioSolutions Manufacturing Partner for Production of COVID-19 Lead Vaccine Candidate
Enzo Biochem Launches Proprietary COVID-19 Diagnostic Test
Siemens to Offer Laboratory-Based SARS-CoV-2 Total Antibody Test with Time to First Result of 14 Minutes
In Vitro Confirmation of COVID-19 Drug Candidates Done Using AI-based Screening Technology
Anti-Parasitic Drug, Ivermectin, Eliminates SARS-CoV-2 in Cells in 48 Hours
Antibodies in Llama Blood Could Hold Key to Developing COVID-19 Vaccine
Hillrom Launches New Innovations to Help Diagnose and Treat COVID-19 Patients
ChromaCode Launches High-Throughput HDPCR SARS-CoV-2 Real-Time Assay
NovaBay to Distribute COVID-19 Antibody Rapid, Finger Prick Point-of-Care Test
Seegene's Allplex 2019-nCoV Assay Receives FDA Emergency Use Authorization
Pfizer and BioNTech to Start Germany’s First COVID-19 Vaccine Clinical Trial
‘Contactless’ COVID-19 Trial to Test Common Anti-Inflammatory Drug Colchicine
Big Data Used to Search Billions of Molecules for Promising Compounds Against COVID-19
Molecular Beacons Technology Used in Rapid COVID-19 Tests
